Innovative solutions for blood purification |
monitoring patient in ICU exposure to extracorporeal circulation
We develop solutions to improve the management of patients likely to be exposed to medical devices used in extracorporeal circulation (MDEC):
Innovative technology
to tackle sequestration
Unique patented in vitro method to evaluate the sequestration of drugs by medical devices used in extracorporeal circulation.
R&D&I on qualifying the best materials for medical devices
New medical devices and treatments to specifically target molecules of interest such as contaminants in the context of EIDs and NRBC.
Digital tools development to better assist clinicians
Developing a decision companion for health professionals to make the right choices for patients in ICU.
Services for MD manufacturers
We are developing services for Medical Devices manufacturers who aim to characterize better the capacity of sequestration of their technologies.
Services for MD manufacturers
We are developing services for Medical Devices manufacturers who aim to characterize better the capacity of sequestration of their technologies.
Services for biotech companies developing new drugs used in ICU
We are developing services for companies developing new drugs that may be used in the context of extracorporeal circulation to better monitor the ability of their molecules to be sequestrated by medical devices
We are developing innovation
We are using our unique and patented in vitro method to develop new strategies to specifically capture contaminants and unwanted molecules in the blood in collaboration with academic and industrial partners.